Reduction of dietary phosphorus absorption by phosphorus binders. A theoretical, in vitro, and in vivo study.
about
Hyperphosphatemia Management in Patients with Chronic Kidney DiseaseCalcium citrate and vitamin D in the treatment of osteoporosis.New perspectives on acid-base balance.Intestinal absorption of magnesium from food and supplements.Pharmacology, efficacy and safety of oral phosphate binders.The institute of medicine's "dietary reference intake" for phosphorus: a critical perspective.Comparative effectiveness of calcium-containing phosphate binders in incident U.S. dialysis patientsPharmacology of the phosphate binder, lanthanum carbonateManagement of hyperphosphatemia in patients with end-stage renal disease: focus on lanthanum carbonate.Calcium acetate or calcium carbonate for hyperphosphatemia of hemodialysis patients: a meta-analysis.Lanthanum carbonate reduces urine phosphorus excretion: evidence of high-capacity phosphate binding.Studies of osmotic diarrhea induced in normal subjects by ingestion of polyethylene glycol and lactuloseThe safety of phosphate binders.Nephrology, dialysis and transplantationEffects of Proton Pump Inhibitor Administration and Intake of a Combination of Yogurt and Galactooligosaccharides on Bone and Mineral Metabolism in RatsTreatment options for hyperphosphatemia in feline CKD: what's out there?Sevelamer carbonate for the treatment of hyperphosphatemia in patients with kidney failure (CKD III - V).Optimal use of phosphate binders in chronic kidney disease.Oral phosphate binders: phosphate binding capacity of iron (III) hydroxide complexes containing saccharides and their effect on the urinary excretion of calcium and phosphate in rats.Contemporary management of phosphorus retention in chronic kidney disease: a review.Advances in pharmacotherapy for hyperphosphatemia in renal disease.A Review of Phosphate Binders in Chronic Kidney Disease: Incremental Progress or Just Higher Costs?Phosphate binders in patients with chronic kidney disease.Left ventricular dyssynchrony in patients with moderate coronary stenosis and border line fractional flow reserveEffect of Patiromer on Urinary Ion Excretion in Healthy AdultsNephrology, dialysis and transplantation.Lanthanum carbonate.Role of calcium carbonate administration timing in relation to food intake on its efficiency in controlling hyperphosphatemia in patients on maintenance dialysis.Additional benefit of dietitian involvement in dialysis staffs-led diet education on uncontrolled hyperphosphatemia in hemodialysis patients.Is lanthanum carbonate safer and more effective than calcium carbonate for hyperphosphatemia in dialysis patients?Effect of gastric acid suppression with pantoprazole on the efficacy of calcium carbonate as a phosphate binder in haemodialysis patients
P2860
Q26743842-CD4C5C6E-969D-48F2-8FC2-733D28D26AD6Q33449783-F1BE84A5-6208-4B53-91B7-878116760D5DQ33989119-6E8CFB3C-E57E-4A61-8B03-EFF185F32C4DQ34191620-67A9536F-F2A8-46FB-98D5-5CD88B60A7E7Q34213752-24268CF5-5B67-41D7-B5F6-E6CA134C4C7AQ34337598-9B9F6E13-FA81-4748-9A92-18F82F82FE1EQ34497220-F27A2E4D-C9F9-45E1-B0F5-718ABE2546D3Q34854318-CDC5E049-1E21-4327-A176-1786B5293932Q35026657-2C7DE4FF-3BE2-4FD5-9250-A84E892C51D6Q35209016-D465099D-B67A-42C1-BFC2-491612A3998CQ35811676-0F61E3B7-DDC0-4B58-8710-946EC73CC8C0Q35815166-587BBF0D-513C-430A-8E54-94A9552ABF86Q36565049-F26FCF09-EABF-4E82-9EB3-C52E38DC87ACQ36683763-E54870E6-0401-4D25-88D3-DC90C44E68D2Q37373993-6BE82141-1B1A-496F-B1EC-C9761452BFF0Q37621711-B0D49477-A4CE-4E05-A075-D529A73FB9CCQ37803240-875B7AB8-CC95-4B26-909B-33F794B59E03Q38161580-028090F7-5748-4EF2-ABCE-6DEDD812CF19Q38319620-37A06BDC-2D8D-43DC-B198-60F7852A4202Q38511621-33F6DB9D-8F63-4370-B313-36B9917FAE9BQ38587575-1418DDF0-36C7-48B7-BDC5-CC54CB5A65B5Q38741675-6551D338-B601-414D-8F37-37F142EE58E7Q39155279-D49B4815-34A5-40D8-A548-CA1D34BB81ABQ42279069-D94A1AD5-946E-4EE1-84B1-4A38B501EE5BQ42386508-1EC063BD-BBAA-4B49-AA5B-CEA1CF51954EQ42973858-D2DA4C2A-1153-42EC-A657-F13DF3E38713Q46921582-BCD7082E-9D26-46C2-8DC3-44CA9F189D07Q47765173-C08D493F-50BC-4B0F-A88B-2FDF6E60C64EQ53251908-1007694E-00A9-40A9-BBC6-9306BEFADC4DQ56611269-3E72E7D1-0B04-4C10-AF0C-616437EC27A2Q57218510-A027A31C-04E9-4276-8C99-44E9521DB350
P2860
Reduction of dietary phosphorus absorption by phosphorus binders. A theoretical, in vitro, and in vivo study.
description
1989 nî lūn-bûn
@nan
1989 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Reduction of dietary phosphoru ...... , in vitro, and in vivo study.
@ast
Reduction of dietary phosphoru ...... , in vitro, and in vivo study.
@en
Reduction of dietary phosphoru ...... , in vitro, and in vivo study.
@nl
type
label
Reduction of dietary phosphoru ...... , in vitro, and in vivo study.
@ast
Reduction of dietary phosphoru ...... , in vitro, and in vivo study.
@en
Reduction of dietary phosphoru ...... , in vitro, and in vivo study.
@nl
prefLabel
Reduction of dietary phosphoru ...... , in vitro, and in vivo study.
@ast
Reduction of dietary phosphoru ...... , in vitro, and in vivo study.
@en
Reduction of dietary phosphoru ...... , in vitro, and in vivo study.
@nl
P2093
P2860
P356
P1476
Reduction of dietary phosphoru ...... , in vitro, and in vivo study.
@en
P2093
C A Santa Ana
J A Maguire
J S Fordtran
L R Schiller
M S Sheikh
P2860
P356
10.1172/JCI113886
P407
P577
1989-01-01T00:00:00Z